From Riva-Rocci until Miocardial Intersticial Fibrosis: The Seven Errors Game in Arterial Hypertension -Misconceptions Review

Main Article Content

Claudio Pinho, MD, PhD, FESC, FACC Eni Pereira Berci Pinho, MD


Knowledge of cardiac, renal and vascular injuries that occur in Arterial Hypertension has been known for a long time, however, their correlation with high blood pressure levels can only occur after the dissemination of the measure developed by Riva-Rocci and perfected by Korotkoff at the beginning of the 20th century. This correlation was initially imagined with false assumptions, which led not only to inertia but also to an opposition to the decrease in blood pressure levels that lasted around five decades. These false assumptions are named and analyzed. Even after the definition that the drop in blood pressure levels should be an obligatory part of the treatment of this condition, other erroneous understandings of this pathology have continued to occur until today. In this review, which covers the last one hundred and thirty years, we found, enumerated and analyzed seven of these errors based on the current knowledge we have gained on Arterial Hypertension and exposed their differences, simulating a game of seven errors.

The aim of Science is not to open a door to endless wisdom, but to put a limit on endless error.

Bertold Brecht: The Life of Galileo

Article Details

How to Cite
PINHO, Claudio; PINHO, Eni Pereira Berci. From Riva-Rocci until Miocardial Intersticial Fibrosis: The Seven Errors Game in Arterial Hypertension -Misconceptions Review. Medical Research Archives, [S.l.], v. 12, n. 4, may 2024. ISSN 2375-1924. Available at: <>. Date accessed: 27 may 2024. doi:
Review Articles


1- Moser, M. Evolution of the treatment of Hypertension from the 1940s to JNC V. Amer J Hypertension 10:2S-8S 1997

2- Moser, M. Historical perspectives on the management of Hypertension. J Clin Hypertension 8(8) S2:15-20 2006

3- Allbutt, D. Senile plethora or high arterial pressure in elderly persons. Trans Hunter Soc,1895

4- Sambhi, M.P. Essential Hypertension In: Arterial Hypertension, J. Rosenthal (ed) Springer-Verlag New York, Inc. 1982

5- Rosenthal, T. Contemplating the history of Drug therapy for Hypertension. Blood Pressure 13:262-271 2004

6- Johnson, RJ; Feig, DI; Nakagawa, T; Sanchez-Lozada, G and Rodriguez-Iturbe, B. Pathogenesis of essential Hypertension: historical paradigms and modern insights. J Hypertens 26(3): 381-391 2008

7- Perera, G.A. Hypertensive vascular disease; description and natural history. J Chronic Dis. 1(1): 33-42 1955 doi:10.1016/0021-9681(55)90019-

8- Perera, G.A. The Lewis A Conner Memorial Lecture Primary Hypertension. Circulation XIII(3) 321-328 1956

9- Wertheim, R.; Deming, Q.B. Management of patient with primary (essential) hypertension. J Chronic Dis 1(5) 574-588 1955

10- Syed S. Mahmooda, Daniel Levyb,c, Ramachandran S. Vasanb,d, and Thomas J. Wang. The Framingham Heart Study and the epidemiology of cardiovascular disease: A historical perspective. Lancet 383(9921): 999–1008 2014. doi:10.1016/S0140-6736(13)61752-3.

11- Veterans Administration Cooperative Study Group on antihypertensive agents. Effects of treatment on morbidity in hypertension. Results in patients with diastokic blood pressures averaging 115 through 129 mmHg, JAMA 202:1028-1034 1967

12- Veterans Administration Cooperative Study Group on antihypertensive agents. III. Influence of age, diastolic pressure and prior cardiovascular disease; further analysis of side effects. Circulation. 45:991-2004 1972

13- Smirk, H. The prognosis of untreated and of treated hypertension and advantages of early treatment. Am Heart J 83(6) 825-840 1972

14- Wolf, M; Ewen, S; Mahfoud, F and Bohm, M. Hypertension: history and development of established and novel treatments, Clin Res Cardiol 107: S16-S29 2018

15- Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. JAMA. 237(3):255-61 1977

16- 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39, 3021–3104 2018 ESC/ESH GUIDELINES doi:10.1093/eurheartj/ehy339

17- Laragh, JH; Baer, L; Brunner, HR; Buhler, FR and Vaughan, JE. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Amer J Med 57(5) 633-652 1972

18- Harrison, DG; Coffman, TM and Wilcox, CS. Pathophysiology of Hypertension – The mosac theory and Beyond. Circulation Res 128: 847-863 2021 doi:10.1161/CIRCRESAHA.121.318082

19- Paulus, WJ and Zile, MR. From systemic inflamation to myocardial fibrosis. The heart Failure with preserved ejection fraction paradigm revisited. Circulation Res128: 1451-1467 2021 doi:10.1161/CIRCRESAHA121.318159

20- Chehab, O; Abdollahi, A; Ehelton, SP; Wu, CO; Ambale-Venkatesh, B et al. Association of Lipoprotein(a) levels with myocardial fibrosis in the Multi-ethnic study of atherosclerosis. J Amer Coll Cardiol 82(24)2280-2291 2023

21- Frangogiannis, NG. Cardiac fibrosis. Cardiovasc Res 117: 1450-1488 2021 doi:10.1093/cvr/cvaa324

22- Gonzalez, A; Lopez, B; Ravassa, S; San Jose, G; Latasa,I et al. Myocardial interstitial fibrosis in hypertensive heart disease: from mechanisms to clinical management. Hypertension 2024

23- Nemtsova, V; Visher, AS and Burkard,T. Hypertensive heart disease: A narrative review series – Part 1: Pathophysiology and microstructural Changes. J Clin Med 12:2606 2023

24- Nemtsova, V; Burkard, T and Visher, A. Hyertensive heart disease: A narrative review series – Part 2: Macrostructural and functional abnormalities. J Clin Med 12:5723 2023

25- Nemtsova, V; Visher, AS and Burkard,T. Hypertensive heart disease: A narrative review series – Part 3: Vasculature, biomarkers and the matrix oh hypertensive heart disease. J Clin Med 13:505 2024

26- Bekar, L; Katar,M; Yetim, M; Çelik, O; Kilci, H and Onalan, O. Fragmented QRS complexes are a marker of myocardial fibrosis en hypertensive heart disease. Turk Kardiyol Dem Ars 44(7) 554-560 2016

27- Pinho, C; Dias, DL; Figueiredo, MJO; Rocha, JC; Fornari, N et al. Correlation between ventricular arrhythmias and geometric remodeling of the left ventricle in essential hypertension. Arq Bras Cardiol 61(4) 1993